» Articles » PMID: 35056996

From Microenvironment Remediation to Novel Anti-Cancer Strategy: The Emergence of Zero Valent Iron Nanoparticles

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2022 Jan 21
PMID 35056996
Authors
Affiliations
Soon will be listed here.
Abstract

Accumulated studies indicate that zero-valent iron (ZVI) nanoparticles demonstrate endogenous cancer-selective cytotoxicity, without any external electric field, lights, or energy, while sparing healthy non-cancerous cells in vitro and in vivo. The anti-cancer activity of ZVI-based nanoparticles was anti-proportional to the oxidative status of the materials, which indicates that the elemental iron is crucial for the observed cancer selectivity. In this thematic article, distinctive endogenous anti-cancer mechanisms of ZVI-related nanomaterials at the cellular and molecular levels are reviewed, including the related gene modulating profile in vitro and in vivo. From a material science perspective, the underlying mechanisms are also analyzed. In summary, ZVI-based nanomaterials demonstrated prominent potential in precision medicine to modulate both programmed cell death of cancer cells, as well as the tumor microenvironment. We believe that this will inspire advanced anti-cancer therapy in the future.

Citing Articles

Therapeutic and antioxidant potential of bionanofactory Ochrobactrum sp.-mediated magnetite and zerovalent iron nanoparticles against acute experimental toxoplasmosis.

Hezema N, Eltarahony M, Abdel Salam S PLoS Negl Trop Dis. 2023; 17(10):e0011655.

PMID: 37801440 PMC: 10558077. DOI: 10.1371/journal.pntd.0011655.


Combination effect of cold atmospheric plasma with green synthesized zero-valent iron nanoparticles in the treatment of melanoma cancer model.

Yazdani Z, Biparva P, Rafiei A, Kardan M, Hadavi S PLoS One. 2022; 17(12):e0279120.

PMID: 36534669 PMC: 9762585. DOI: 10.1371/journal.pone.0279120.

References
1.
Machado S, Pacheco J, Nouws H, Albergaria J, Delerue-Matos C . Characterization of green zero-valent iron nanoparticles produced with tree leaf extracts. Sci Total Environ. 2015; 533:76-81. DOI: 10.1016/j.scitotenv.2015.06.091. View

2.
Dagogo-Jack I, Shaw A . Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2017; 15(2):81-94. DOI: 10.1038/nrclinonc.2017.166. View

3.
Ayala A, Munoz M, Arguelles S . Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014; 2014:360438. PMC: 4066722. DOI: 10.1155/2014/360438. View

4.
Sporn M, Liby K . NRF2 and cancer: the good, the bad and the importance of context. Nat Rev Cancer. 2012; 12(8):564-71. PMC: 3836441. DOI: 10.1038/nrc3278. View

5.
Son S, Kim J, Wang X, Zhang C, Yoon S, Shin J . Multifunctional sonosensitizers in sonodynamic cancer therapy. Chem Soc Rev. 2020; 49(11):3244-3261. DOI: 10.1039/c9cs00648f. View